Given the manifestation of NMDAR excitotoxicity and abnormal activity in neurodegenerative diseases, such as Alzheimer’s disease [19], we propose that stimulating NBCn1 channel activity in neurons might be a valuable approach to reducing excessive glutamate transmission under pathological conditions. Here, SLC4A7 is linked to Alzheimer disease.